REKOVELLE DIN 02474085
Status: Cancelled Post Market
Holder: FERRING INC
Health Canada record
| Active ingredient(s) | FOLLITROPIN DELTA 36 MCG |
|---|
| Dosage form | Solution |
|---|
| Route | Subcutaneous |
|---|
| Schedule | PRESCRIPTION; SCHEDULE D |
|---|
| Class | Human |
|---|
| ATC | G03GA10 FOLLITROPIN DELTA |
|---|
| Original market date | 23-May-2018 |
|---|
| Current status date | 06-May-2021 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Ferring Inc. — licence 100274, currently licensed, last inspection rating C (2026-05-19).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FOLLITROPIN DELTA
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02487462 | REKOVELLE | FERRING INC | Solution | FOLLITROPIN DELTA 12 MCG | Marketed |
| 02487470 | REKOVELLE | FERRING INC | Solution | FOLLITROPIN DELTA 36 MCG | Marketed |
| 02487489 | REKOVELLE | FERRING INC | Solution | FOLLITROPIN DELTA 72 MCG | Marketed |
| 02474077 | REKOVELLE | FERRING INC | Solution | FOLLITROPIN DELTA 72 MCG | Cancelled Post Market |
| 02474093 | REKOVELLE | FERRING INC | Solution | FOLLITROPIN DELTA 12 MCG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 20653 | 2018-03-22 | New Drug Submission (NDS) | |
Request a quote for REKOVELLE
How to read a Canadian DIN record